XuXin Sun

XuXin Sun

Auto-generated profile, based on publicly available information

XuXin Sun

Basic and Translational Research Department, BC Cancer Research Institute, Vancouver, BC, Canada; Cuprous Pharmaceuticals Inc. Vancouver, BC, Canada; Nanomedicine Innovation Network, University of British Columbia, Vancouver, BC, Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2026 in Cancer Letters
Verified
Journal Article
Open access
DHDevon Heroux
Devon Heroux
XSXu Xin Sun
Xu Xin Sun
SZSijie Zhang
Sijie Zhang
MSMaryam Sharifiaghdam
Maryam Sharifiaghdam
ALAda Wy. Leung
Ada Wy. Leung
MBMarcel B. Bally
Marcel B. Bally
Copper-binding agents can trigger immunogenic cell death (ICD) and modulate responses to immune checkpoint inhibitors (ICIs), but how tumor copper biology, agent chemistry, and tumor microenvironment shape these effects is unclear. We evaluated diethyldithiocarbamate [Cu(DDC)2] and clioquinol [Cu(CQ)2] in two syngeneic colorectal cancer models with distinct copper handling. In vitro transcriptomic and cytokine profiling showed compound-specific activation of cuproptosis and immune pathways. In vivo, copper accumulation and isotopic fractionation correlated with immune features of the tumor microenvironment, including immune cell infiltration and calreticulin exposure. In CT26 tumors, Cu(CQ)2 transiently enhanced programmed cell death protein 1 (PD-1) blockade, then promoted immune suppression with prolonged dosing. In MC38 tumors, combination therapy showed sustained antagonism or no added benefit. These data indicate that tumor-intrinsic copper handling and ionophore identity jointly determine immune dynamics and therapeutic outcome, and they suggest copper isotopic metrics as candidate biomarkers warranting further evaluation in the context of copper-based strategies with ICIs.

1 October 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Open access
MSMaryam Sharifiaghdam
Maryam Sharifiaghdam
XSXuXin Sun
XuXin Sun
ALAda Leung
Ada Leung
NSNancy Dos Santos
Nancy Dos Santos
NWNicole Wretham
Nicole Wretham
MBMarcel B. Bally
Marcel B. Bally

25 May 2026 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
XSXuXin Sun
XuXin Sun
MSMaryam Sharifiaghdam
Maryam Sharifiaghdam
NSNasim Sarrami
Nasim Sarrami
IPIoana Popescu
Ioana Popescu
NWNicole Wretham
Nicole Wretham
MBMarcel Bally
Marcel Bally
A liposomal CPT-11 formulation was previously developed and approved for pancreatic cancer (Onivyde), but it carries a FDA black-box warning because it exacerbated CPT-11 associated gastrointestinal (GI) toxicities. An alternative liposomal irinotecan formulation, Irinophore C, reduced GI toxicity as judged by a validated animal model of irinotecan mediated early and late onset diarrhea. Irinophore C did not progress to clinical trials, partly because its development coincided with the approval of Onivyde. Nevertheless, an Irinophore C-like formulation remains of interest because of its potential to reduce GI toxicity and its potential to be developed as a combination product. Irinophore C was prepared using liposomes containing entrapped copper (Cu2+). The divalent metal ionophore A23187 was used to exchange entrapped Cu2+ for protons, creating a transmembrane pH gradient. Following addition of CPT-11 to the liposomes, it crossed into the liposome interior to achieve efficient (>95%) liposome association. The results were consistent with previous findings that CPT-11 can be loaded into liposomes with a transmembrane pH gradient (inside acid). The presence of copper, however, imparted unique properties. The resulting formulation retained CPT-11 better than liposomes loaded using a simple transmembrane pH gradient or a pH gradient generated with A23187 added to liposomes containing other divalent metal ions (e.g., Mg2+, Mn2+, Zn2+). The data suggested improved drug retention arose due to Cu2+ binding with CPT-11 and/or with lipids in the inner membrane of the liposomes. It was further suggested that Cu2+ may mitigate GI toxicity. In this study it is argued that if Cu2+ ions confer unique advantages to the liposomal CPT-11 formulation, then the original method used to prepare Irinophore C was not optimal. This is because A23187 significantly reduced the amount of copper retained in the liposomes. Here, we characterize an alternative method for CPT-11 encapsulation; a method that retains Cu2+ within liposomes. In this formulation, A23187 is not required and the low internal pH is maintained with ammonium sulfate. The results showed that CPT-11 can be efficiently loaded into these liposomes, achieving CPT-11 to liposomal-lipid ratios exceeding 0.6 (mol:mol). The resulting formulation exhibits significantly improved drug retention and cryo-transmission electron microscopy analysis suggests the morphology of the new formulation differs from Irinophore C. Efficacy studies in a syngeneic BALB/c CT26 colorectal cancer model demonstrated the therapeutic potential of the new formulation, but highlight a challenge when developing high CPT-11 to liposomal-lipid ratio formulations. Specifically, high drug to liposomal-lipid formulations utilize significantly lower lipid doses that are eliminated rapidly after administration. It is suggested that this new formulation is suitable for development in combination with other therapies, however the rapid elimination of the liposomes administered at low liposomal lipid dosed must be addressed.

8 January 2021 in ChemRxiv
Verified
Preprint
Open access
PDF file
ZWZoey Warmerdam
Zoey Warmerdam
BKBianca Kamba
Bianca Kamba
ASAlok Shaurya
Alok Shaurya
XSXuXin Sun
XuXin Sun
MMMary Maguire
Mary Maguire
FHFraser Hof
Fraser Hof
Preprint manuscript, including synthesis of new compounds and fluorescence/NMR-based binding data. We present the synthesis and structure-activity relationships of sulfonatocalix[4]arene hosts bearing novel substitutions. The calix[4]arenes are modified on the upper rim at either one or two of the phenolic units, where the dual modifications are introduced selectively on neighboring or opposing phenols. The calix[4]arenes are mono- or di-functionalized with nitro or formyl groups, with the remaining upper-rim sites in all cases occupied by sulfonates. Equilibrium association constants were determined between each host and the guests nicotine, nornicotine, and cotinine. Indicator displacement-based binding studies show that nicotine binds most strongly to the different members of the library followed by nornicotine, whereas cotinine displays weak to no binding. NMR titrations were carried out with nicotine and show different host-guest interaction geometries for the formyl-calix[4]arenes versus the nitro-calix[4]arenes.